Serena Williams is opening up about her fitness journey, revealing that she uses the injectable GLP-1 weight loss drug ...

The 23-time Grand Slam champion recently opened up to PEOPLE exclusively about using a GLP-1 medication to help with weight ...

Serena Williams shares she is now using a GLP-1 in partnership with Ro, a digital health care company. Find out why she’s not ...

Serena Williams revealed how she turned her health around with help of a GLP-1 medication after she struggled to lose weight following the birth of her two daughters.

Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss drug.

For reasons that remain unclear, kidney cancer risk was higher in users of GLP-1 agonists, particularly those under 65 and those who were overweight versus obese.< Patients taking GLP-1 agonists for ...

Serena Williams has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an exclusive TODAY interview.

Serena Williams is getting real about her weight-loss journey. Since April, the retired tennis legend has been on a GLP-1 ...

But what is important to me is transparency.” That calling has led her to this very moment: Williams is ready to share that ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.

Columnist Teri Sforza writes that studies have found that semaglutide reduced alcohol intake, binge drinking and relapse ...

Older adults with diabetes using GLP-1 receptor agonist medications may face increased risk of serious eye conditions, study ...